CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 6, 2013, Pages 1542-1552

  Ishikawa, Chie ^a   Kawakami, Hirochika ^a   Uchihara, Jun Nosuke ^b   Senba, Masachika ^c   Mori, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Naha City Hospital   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

ATL; CD69; Deacetylation; HTLV 1; NF B; Tax

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CD69 ANTIGEN; CYCLIC AMP; EARLY GROWTH RESPONSE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TAX PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL LINE; CLINICAL ARTICLE; DEACETYLATION; EPIGENETICS; FLOW CYTOMETRY; GENE CONTROL; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOCYTE; METHYLATION; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SKIN DEFECT;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLOTTING, WESTERN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOENZYME TECHNIQUES; LECTINS, C-TYPE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LEUKOCYTES, MONONUCLEAR; LUCIFERASES; NF-KAPPA B; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED; UP-REGULATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84876078772     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.03.006     Document Type: Article

References (59)

1. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:6476-6480.
2. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:7415-7419.
3. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986, i:1031-1032.
4. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, ii:407-410.
5. Mochizuki M., Watanabe T., Yamaguchi K., Takatsuki K., Yoshimura K., Shirao M., Nakashima S., Mori S., Araki S., Miyata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res. 1992, 83:236-239.
6. Nishioka K., Maruyama I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989, i:441.
7. Hamann J., Fiebig H., Strauss M. Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. J. Immunol. 1993, 150:4920-4927.
8. Ziegler S.F., Ramsdell F., Hjerrild K.A., Armitage R.J., Grabstein K.H., Hennen K.B., Farrah T., Fanslow W.C., Shevach E.M., Alderson M.R. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 1993, 23:1643-1648.
9. Sánchez-Mateos P., Cebrián M., Acevedo A., López-Botet M., De Landázuri M.O., Sánchez-Madrid F. Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. Immunology 1989, 68:72-79.
10. Cebrián M., Yagüe E., Rincón M., López-Botet M., de Landázuri M.O., Sánchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 1988, 168:1621-1637.
11. García-Monzón C., Moreno-Otero R., Pajares J.M., García-Sánchez A., López-Botet M., de Landázuri M.O., Sánchez-Madrid F. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology 1990, 98:1029-1035.
12. Laffón A., García-Vicuña R., Humbría A., Postigo A.A., Corbí A.L., de Landázuri M.O., Sánchez-Madrid F. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 1991, 88:546-552.
13. Testi R., Phillips J.H., Lanier L.L. T cell activation via Leu-23 (CD69). J. Immunol. 1989, 143:1123-1128.
14. Esplugues E., Sancho D., Vega-Ramos J., Martínez C., Syrbe U., Hamann A., Engel P., Sánchez-Madrid F., Lauzurica P. Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 2003, 197:1093-1106.
15. Sancho D., Gómez M., Viedma F., Esplugues E., Gordón-Alonso M., García-López M.A., de la Fuente H., Martínez-A C., Lauzurica P., Sánchez-Madrid F. CD69 downregulates autoimmune reactivity through active transforming growth factor-β production in collagen-induced arthritis. J. Clin. Invest. 2003, 112:872-882.
16. Cruz-Adalia A., Jiménez-Borreguero L.J., Ramírez-Huesca M., Chico-Calero I., Barreiro O., López-Conesa E., Fresno M., Sánchez-Madrid F., Martín P. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation 2010, 122:1396-1404.
17. Martín P., Gómez M., Lamana A., Matesanz Marín A., Cortés J.R., Ramírez-Huesca M., Barreiro O., López-Romero P., Gutiérrez-Vázquez C., de la Fuente H., Cruz-Adalia A., Sánchez-Madrid F. The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. J. Allergy Clin. Immunol. 2010, 126:355-365.
18. Feng C., Woodside K.J., Vance B.A., El-Khoury D., Canelles M., Lee J., Gress R., Fowlkes B.J., Shores E.W., Love P.E. A potential role for CD69 in thymocyte emigration. Int. Immunol. 2002, 14:535-544.
19. Nakayama T., Kasprowicz D.J., Yamashita M., Schubert L.A., Gillard G., Kimura M., Didierlaurent A., Koseki H., Ziegler S.F. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J. Immunol. 2002, 168:87-94.
20. Lamana A., Martin P., de la Fuente H., Martinez-Muñoz L., Cruz-Adalia A., Ramirez-Huesca M., Escribano C., Gollmer K., Mellado M., Stein J.V., Rodriguez-Fernandez J.L., Sanchez-Madrid F., del Hoyo G.M. CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. J. Invest. Dermatol. 2011, 131:1503-1512.
21. Boxus M., Willems L. Mechanisms of HTLV-I persistence and transformation. Br. J. Cancer 2009, 101:1497-1501.
22. Chlichlia K., Khazaie K. HTLV-1 Tax: liking transformation, DNA damage and apoptotic T-cell death. Chem. Biol. Interact. 2010, 188:359-365.
23. Jeang K.-T. HTLV-1 and adult T-cell leukemia: insights into viral transformation of cells 30years after virus discovery. J. Formos. Med. Assoc. 2010, 109:688-693.
24. Matsuoka M., Jeang K.-T. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 2011, 30:1379-1389.
25. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981, 294:770-771.
26. Yamamoto N., Okada M., Koyanagi Y., Kannagi M., Hinuma Y. Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 1982, 217:737-739.
27. Popovic M., Sarin P.S., Robert-Gurroff M., Kalyanaraman V.S., Mann D., Minowada J., Gallo R.C. Isolation and transmission of human retrovirus (human T-cell leukemia virus). Science 1983, 219:856-859.
28. Miyoshi I., Kubonishi I., Sumida M., Hiraki S., Tsubota T., Kimura I., Miyamoto K., Sato J. A novel T-cell line derived from adult T-cell leukaemia. Gann 1980, 71:155-156.
29. Sugamura K., Fujii M., Kannagi M., Sakitani M., Takeuchi M., Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int. J. Cancer 1984, 34:221-228.
30. Maeda M., Shimizu A., Ikuta K., Okamoto H., Kashihara M., Uchiyama T., Honjo T., Yodoi J. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia: analysis of T cell receptor gene rearrangement. J. Exp. Med. 1985, 162:2169-2174.
31. Yoshida T., Miyagawa E., Yamaguchi K., Kobayashi S., Takahashi Y., Yamashita A., Miura H., Itoyama Y., Yamamoto N. IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II. Int. J. Cancer 2001, 91:99-108.
32. Ohtani K., Nakamura M., Saito S., Nagata K., Sugamura K., Hinuma Y. Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res. 1989, 17:1589-1604.
33. Matsumoto K., Shibata H., Fujisawa J.I., Inoue H., Hakura A., Tsukahara T., Fujii M. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J. Virol. 1997, 71:4445-4451.
34. López-Cabrera M., Muñoz E., Blázquez M.V., Ursa M.A., Santis A.G., Sánchez-Madrid F. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-α-responsive elements. J. Biol. Chem. 1995, 270:21545-21551.
35. Castellanos Mdel C., López-Giral S., López-Cabrera M., de Landázuri M.O. Multiple cis-acting elements regulate the expression of the early T cell activation antigen CD69. Eur. J. Immunol. 2002, 32:3108-3117.
36. Brockman J.A., Scherer D.C., McKinsey T.A., Hall S.M., Qi X., Lee W.Y., Ballard D.W. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 1995, 15:2809-2818.
37. McKinsey T.A., Brockman J.A., Scherer D.C., Al-Murrani S.W., Green P.L., Ballard D.W. Inactivation of IκBβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol. Cell. Biol. 1996, 16:2083-2090.
38. Geleziunas R., Ferrell S., Lin X., Mu Y., Cunningham E.T., Grant M., Connelly M.A., Hambor J.E., Marcu K.B., Greene W.C. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases. Mol. Cell. Biol. 1998, 18:5157-5165.
39. Iha H., Kibler K.V., Yedavalli V.R.K., Peloponese J.M., Haller K., Miyazato A., Kasai T., Jeang K.-T. Segregation of NF-κB activation through NEMO/IKKγ by Tax and TNFα: implications for stimulus-specific interruption of oncogenic signaling. Oncogene 2003, 22:8912-8923.
40. Tanaka Y., Yoshida A., Takayama Y., Tsujimoto H., Tsujimoto A., Hayami M., Tozawa H. Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses. Jpn. J. Cancer Res. 1990, 81:225-231.
41. Mori N., Prager D. Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 1996, 87:3410-3417.
42. Ishikawa C., Nakachi S., Senba M., Sugai M., Mori N. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis. Carcinogenesis 2011, 32:110-119.
43. Inoue J., Seiki M., Taniguchi T., Tsuru S., Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 1986, 5:2883-2888.
44. Koiwa T., Hamano-Usami A., Ishida T., Okayama A., Yamaguchi K., Kamihira S., Watanabe T. 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 2002, 76:9389-9397.
45. Jin D.Y., Giordano V., Kibler K.V., Nakano H., Jeang K.-T. Role of adapter function in oncoprotein-mediated activation of NF-κB. Human T-cell leukemia virus type I Tax interacts directly with IκB kinase γ. J. Biol. Chem. 1999, 274:17402-17405.
46. Jiang H., Lu H., Schiltz R.L., Pise-Masison C.A., Ogryzko V.V., Nakatani Y., Brady J.N. PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol. Cell. Biol. 1999, 19:8136-8145.
47. Baeuerle P.A. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1991, 1072:63-80.
48. Amorino G.P., Mikkelsen R.B., Valerie K., Schmidt-Ullrich R.K. Dominant-negative cAMP-responsive element-binding protein inhibits proliferating cell nuclear antigen and DNA repair, leading to increased cellular radiosensitivity. J. Biol. Chem. 2003, 278:29394-29399.
49. Baylin S.B., Ohm J.E. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?. Nat. Rev. Cancer 2006, 6:107-116.
50. Chung H.-K., Young H.A., Goon P.K.C., Heidecker G., Princler G.L., Shimozato O., Taylor G.P., Bangham C.R.M., Derse D. Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood 2003, 102:4130-4136.
51. Chlichlia K., Moldenhauer G., Daniel P.T., Busslinger M., Gazzolo L., Schirrmacher V., Khazaie K. Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene 1995, 10:269-277.
52. Al-Fahim A., Cabre P., Kastrukoff L., Dorovini-Zis K., Oger J. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased. Cell. Immunol. 1999, 198:1-10.
53. Harhaj N.S., Janic B., Ramos J.C., Harrington W.J., Harhaj E.W. Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients. Virology 2007, 362:99-108.
54. Mori N., Fujii M., Ikeda S., Yamada Y., Tomonaga M., Ballard D.W., Yamamoto N. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood 1999, 93:2360-2368.
55. Shirono K., Hattori T., Hata H., Nishimura H., Takatsuki K. Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia. Blood 1989, 73:1664-1671.
56. Gessain A., Saal F., Morozov V., Lasneret J., Vilette D., Gout O., Emanoli-Ravier R., Sigaux F., de Thé G., Périès J. Characterization of HTLV-I isolates and T lymphoid cell lines derived from French West Indian patients with tropical spastic paraparesis. Int. J. Cancer 1989, 43:327-333.
57. Sagawa K., Koga T., Sasaguri Y., Sadamori N., Nagai K. A novel adult T cell leukemia-derived cell line (SALT-3) susceptible to human immunodeficiency virus type 1 infection. Kurume Med. J. 1995, 42:149-160.
58. Suzushima H., Hattori T., Asou N., Wang J.-X., Nishikawa K., Okubo T., Anderson P., Takatsuki K. Discordant gene and surface expression of the T-cell receptor/CD3 complex in adult T-cell leukemia cells. Cancer Res. 1991, 51:6084-6088.
59. 1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.